Results 1 - 1 of 1
Results 1 - 1 of 1. Search took: 0.017 seconds
[en] The purpose of this study was to investigate the possible role of Cerastes cerastes crude venom (CCV) in attenuating (doxorubicin) DOX oxidative damage in male rats. Forty male rats, matched in age and weight were sorted into four groups, control, CCV-group, DOX-group and CCV + DOX-groups. DOX given as a single dose i.p. injection of 10 mg per kg body weight) induced a significant increase in serum advanced oxidation protein products (AOPP),malondialdehyde (MDA), urea, total proteins, AST, ALT, triglycerides and cholesterol. Meanwhile significant decrease in reduced glutathione (GSH), superoxide dimutase (SOD),uric acid as well as RBCs, platelet counts, hemoglobin content (Hb), haematocrit value (Hct), total leukocytes, neutrophils and lymphocytes count was recorded after 14 days. CCV i.p. injected daily at a dose of 1/4 LD50 for 14 days showed a significant decrease of the content of serum AOPP and MDA, lymphocytes and a significant increase of GSH, uric acid, RBCs count, Hb, Hct, total proteins, triglycerides, neutrophils count compared to control. In DOX+ CCV-group, CCV was given daily for 7 days before DOX, 10 mg/kg, followed by CCV for 7 more days, a significant inhibition of the serum triglycerides, cholesterol, urea and total protein, AST, ALT, AOPP, MDA, and a significant elevation of GSH, SOD, uric acid, RBCs, platelet counts, Hb, Hct, were shown as compared with DOX- group. It could be concluded that CCV at low doses can be used as a natural antioxidant to alleviate oxidative injuries of DOX.